Table 3. Growth Percentage against 60 Human Cancer Cell Lines of the NCI Panel at 10 μM of the Active Conjugates^a.

		Growth percentage
Sub panel cancer cell line		20a	20d	20i	22a
Leukemia	CCRF-CEM	78.85	82.95	81.76	34.67
	HL-60(TB)	101.03	89.70	79.77	50.23
	K-562	59.62	60.36	65.02	40.71
	MOLT-4	84.22	82.05	83.54	29.16
	RPMI-8226	52.34	64.91	70.31	nt
	SR	64.20	67.28	67.67	49.30
Nonsmall cell lung cancer	A549/ATCC	49.02	105.30	95.38	79.42
	EKVX	74.70	77.14	78.09	57.36
	HOP-62	0	56.40	75.58	92.77
	NCI-H226	62.14	64.53	50.41	67.25
	NCI-H23	62.14	63.80	66.01	66.57
	NCI-H322M	54.87	86.07	98.04	88.69
	NCI-H460	33.48	80.34	97.55	89.80
	NCI-H522	72.97	60.29	68.60	59.35
Colon cancer	COLO 205	70.91	104.24	109.93	71.22
	HCC-2998	83.57	90.82	100.83	97.97
	HCT-116	24.55	53.45	67.59	69.99
	HCT-15	81.17	90.10	90.22	68.56
	HT29	71.71	89.95	97.66	69.68
	KM12	71.65	78.80	90.31	73.28
	SW-620	67.32	98.94	95.44	84.70
CNS cancer	SF-268	79.65	45.48	92.63	78.89
	SF-295	64.90	48.03	84.25	68.78
	SF-539	70.24	48.16	88.44	80.83
	SNB-19	54.05	58.55	99.55	77.05
	SNB-75	48.71	57.78	83.48	83.14
	U251	48.58	83.96	101.81	80.52
Melanoma	LOX IMVI	55.24	83.41	88.92	55.24
	M14	69.64	99.73	93.30	nt
	MDA-MB-435	66.39	100.01	101.19	90.22
	SK-MEL-2	71.89	111.03	104.61	86.68
	SK-MEL-28	78.87	85.18	107.28	104.42
	SK-MEL-5	46.26	86.57	89.84	105.37
	UACC-257	77.56	98.18	105.03	100.67
	UACC-62	39.61	65.48	67.54	67.51
Ovarian cancer	IGROV1	53.49	58.44	92.89	73.71
	OVCAR-3	77.31	68.29	87.99	88.32
	OVCAR-4	11.25	0.69	85.10	71.67
	OVCAR-5	100.97	77.67	91.08	101.99
	OVCAR-8	24.96	45.17	98.03	71.26
	NCI/ADR-RES	79.62	43.35	87.04	56.51
	SK-OV-3	11.82	48.61	82.58	85.74
Renal cancer	786-0	22.25	11.98	95.60	89.26
	A498	56.81	92.53	77.79	73.28
	ACHN	41.17	56.05	85.14	76.55
	CAKI-1	33.60	nt	nt	nt
	RXF 393	54.11	68.76	70.61	54.00
	SN 12C	49.04	70.47	95.72	83.06
	TK-10	84.10	97.67	104.24	91.69
	UO-31	58.74	52.79	64.01	45.03
Prostate cancer	PC-3	37.64	72.50	87.90	56.85
	DU-145	62.03	88.70	89.79	94.93
Breast cancer	MCF7	55.23	66.88	83.70	58.79
	MDA-MB-231/ATCC	67.10	63.87	78.30	70.64
	HS 578T	63.17	83.68	93.67	81.05
	BT-549	108.01	76.95	76.43	75.03
	T-47D	48.58	65.02	58.86	42.98
	MDA-MB-468	53.75	58.92	48.07	51.81
	Mean GP	59.69	71.72	85.48	72.88

^ant = not tested; GP = growth percentage.